MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to announce results of the Phase 2 clinical trial undertaken by its wholly-owned subsidiary PhytoTech Therapeutics Ltd. As previously announced, PTL is to be sold by MMJ to Harvest One Cannabis Inc. (CVE:HVT), subject to MMJ shareholder approval.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company advises that the conditions precedent have been met for the lease of a Northern NSW property to be used for the growing of medicinal cannabis strains as a primary source for its own manufacture within its Southport manufacturing facility.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides an update on its current portfolio metrics.
Queensland Bauxite Limited (ASX:QBL) is delighted to announce that Medcan Australia, has now been issued with both an Import & Export Licence under the ODC.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) has invested CAD$0.15m for a 2.5% shareholding in privately-held Embark Health Inc as part of their CAD$1m seed funding round.
As reported in the announcement released by Queensland Bauxite Limited (ASX:QBL) on 13th July 2018, the Notice of Meeting for the recompliance transactions is still being drafted and is yet to be reviewed by the ASX. The following table is the timeline to which the Company is currently working towards for the completion of the transactions and the recompliance requirements.
Since a Q&A on the ASX forum was announced (2 July '18), Queensland Bauxite Limited (ASX:QBL) has received many questions mainly by shareholders who were daunted by the 131 page announcement and are eager to understand further the Company's current strategy.
